Mohamed F M Mitwally

other 2006

Nezhat et al. Laparoscopic management of hepatic endometriosis: report of two cases and review of the literature

Journal of Minimally Invasive Gynecology ·doi:10.1016/j.jmig.2005.07.006

review 2005

The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment

Reproductive biology and endocrinology : RB&E ·doi:10.1186/1477-7827-3-54

Clinical utilization of ovulation stimulation to facilitate the ability of a couple to conceive has not only provided a valuable therapeutic approach, but has also yielded extensive information on the physiology of ovarian follicular recrui…

nonrandomized-trial 2004

Aromatase inhibition reduces the dose of gonadotropin required for controlled ovarian hyperstimulation

Journal of the Society for Gynecologic Investigation ·doi:10.1016/j.jsgi.2004.03.006

OBJECTIVE: To compare the use of the aromatase inhibitor, letrozole, in conjunction with follicle-stimulating hormone (FSH) injection, and FSH alone for controlled ovarian hyperstimulation (COH) in patients with polycystic ovarian syndrome …

other 2004

Potential cofounders in the laparoscopic detection of endometriosis

Fertility and sterility ·doi:10.1016/j.fertnstert.2004.04.001

review 2003

Endometriosis from thelarche to midteens: pathogenesis and prognosis, prevention and pedagogy

Journal of Pediatric and Adolescent Gynecology ·doi:10.1016/j.jpag.2003.09.008

John Huffman, a founder of the subspecialty of pediatric and adolescent gynecology in North America, first related the diagnosis of endometriosis to thelarche. Subsequently, endometriosis was diagnosed in early puberty between thelarche and…

other 2003

Isolated hepatic endometriosis: as rare as hens' teeth, but sometimes you can learn a lot from a hen with teeth

Fertility and sterility ·doi:10.1016/s0015-0282(03)02170-8

nonrandomized-trial 2002

Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome

Menopause (New York, N.Y.) ·doi:10.1097/00042192-200207000-00004

OBJECTIVE: To examine the utility of a low-dose estrogen and pulsed progestogen hormone replacement therapy (HRT) regimen for add-back during long-term gonadotropin-releasing hormone-agonist (GnRH-agonist) therapy. DESIGN: A pilot clinical…